Access to hematopoietic stem-cell transplantation in India.
作者信息
Kulkarni U, George B
机构信息
Department of Haematology, Christian Medical College, Vellore, Tamil Nadu, India.
出版信息
J Postgrad Med. 2019 Jan-Mar;65(1):1-4. doi: 10.4103/jpgm.JPGM_391_18.
Abstract
摘要
相似文献
1
Access to hematopoietic stem-cell transplantation in India.印度造血干细胞移植的可及性。
J Postgrad Med. 2019 Jan-Mar;65(1):1-4. doi: 10.4103/jpgm.JPGM_391_18.
2
Hematopoietic stem cell transplantation in nonmalignant diseases.
J Rheumatol Suppl. 1997 May;48:30-5.
3
Alemtuzumab, fludarabine and melphalan as a conditioning therapy in severe aplastic anemia and hypoplastic myelodysplastic syndrome--single center experience.阿仑单抗、氟达拉滨和美法仑作为严重再生障碍性贫血和低增生性骨髓增生异常综合征的预处理疗法——单中心经验
Jpn J Clin Oncol. 2006 Jan;36(1):46-9. doi: 10.1093/jjco/hyi211. Epub 2006 Jan 19.
4
Outcomes of a novel rituximab-based non-myeloablative conditioning regimen for hematopoietic cell transplantation in severe aplastic anemia.一种基于利妥昔单抗的新型非清髓性预处理方案用于重型再生障碍性贫血造血细胞移植的疗效
Bone Marrow Transplant. 2018 Jun;53(6):795-799. doi: 10.1038/s41409-018-0124-6. Epub 2018 Mar 14.
5
Hematopoietic stem cell allografts using a non-myeloablative conditioning regimen can be safely performed on an outpatient basis: report of four cases.
Bone Marrow Transplant. 2000 Jan;25(2):131-3. doi: 10.1038/sj.bmt.1702100.
6
Total costs and clinical outcome of hematopoietic stem cell transplantation in adults with leukemia: comparison between reduced-intensity and myeloablative conditioning.成人白血病患者造血干细胞移植的总成本及临床结局：减低强度预处理与清髓性预处理的比较
Clin Transplant. 2015 Feb;29(2):124-33. doi: 10.1111/ctr.12492. Epub 2014 Dec 20.
7
[Transplantation of hematopoietic stem cells].[造血干细胞移植]
Internist (Berl). 1996 Mar;37(3):295-303.
8
[Progresses in studies on allogeneic hematopoietic stem cell transplantation in children with acquired severe aplastic anemia].[获得性重型再生障碍性贫血患儿异基因造血干细胞移植的研究进展]
Zhonghua Er Ke Za Zhi. 2013 May;51(5):345-8.
9
Haploidentical stem cell transplantation with purified CD34+ cells after a chemotherapy-alone conditioning regimen in heavily transfused severe aplastic anemia.
Biol Blood Marrow Transplant. 2005 May;11(5):399-400. doi: 10.1016/j.bbmt.2005.02.007.
10
Second allogeneic hematopoietic stem cell transplantation in children with severe aplastic anemia.重型再生障碍性贫血患儿的第二次异基因造血干细胞移植
Bone Marrow Transplant. 2015 Oct;50(10):1312-5. doi: 10.1038/bmt.2015.153. Epub 2015 Jun 29.
引用本文的文献
1
Advances in the Treatment of Acute Myeloid Leukemia: Implications for Low- and Middle-Income Countries.急性髓系白血病治疗进展：对低收入和中等收入国家的影响
Biomedicines. 2025 May 18;13(5):1221. doi: 10.3390/biomedicines13051221.
2
Recent advancements in biomarkers, therapeutics, and associated challenges in acute myeloid leukemia.急性髓细胞白血病的生物标志物、治疗方法及相关挑战的最新进展。
Ann Hematol. 2024 Nov;103(11):4375-4400. doi: 10.1007/s00277-024-05963-x. Epub 2024 Aug 29.
3
Real-World Challenges of Haplo-Identical Hematopoietic Stem Cell Transplant in a Developing Country: A Single Center Experience.发展中国家单倍体相合造血干细胞移植的现实挑战：单中心经验
Cureus. 2024 May 6;16(5):e59744. doi: 10.7759/cureus.59744. eCollection 2024 May.
4
Comparable outcomes with low-dose and standard-dose horse anti-thymocyte globulin in the treatment of severe aplastic anemia.低剂量与标准剂量马抗胸腺细胞球蛋白治疗重型再生障碍性贫血的疗效比较
Blood Res. 2024 Feb 26;59(1):6. doi: 10.1007/s44313-024-00003-z.
5
Bone marrow transplant: A two-decade single centre hematology experience.骨髓移植：二十年单中心血液学经验。
Med J Armed Forces India. 2023 Nov-Dec;79(6):657-664. doi: 10.1016/j.mjafi.2023.09.005. Epub 2023 Sep 13.
6
Fludarabine melphalan versus fludarabine treosulfan for reduced intensity conditioning regimen in allogeneic hematopoietic stem cell transplantation: a retrospective analysis.氟达拉滨-马法兰与氟达拉滨-三氧化二砷用于异基因造血干细胞移植中降低强度预处理方案：回顾性分析。
Int J Hematol. 2024 Jan;119(1):71-79. doi: 10.1007/s12185-023-03674-z. Epub 2023 Nov 12.
7
Review of the unmet medical need for vaccination in adults with immunocompromising conditions: An Indian perspective.免疫功能低下成人疫苗接种未满足医学需求的综述：印度视角。
Hum Vaccin Immunother. 2023 Aug 1;19(2):2224186. doi: 10.1080/21645515.2023.2224186.
8
Commentary on: Aqueous-deficient dry eye and systemic disease - More than meets the eye.关于《水液缺乏型干眼与全身性疾病——不止于表面所见》的述评
Indian J Ophthalmol. 2023 Apr;71(4):1545. doi: 10.4103/IJO.IJO_3411_22.
9
Cost of HSCT in a Tertiary Care Public Sector Hospital in India.印度一家三级医疗公立部门医院的造血干细胞移植成本。
Indian J Hematol Blood Transfus. 2022 Jan;38(1):78-83. doi: 10.1007/s12288-021-01421-0. Epub 2021 Mar 8.
10
Haploidentical Hematopoietic Stem Cell Transplantation in Leukemia's: Experience from a Cancer Center in India.单倍体相合造血干细胞移植治疗白血病：来自印度一家癌症中心的经验。
Indian J Hematol Blood Transfus. 2021 Jul;37(3):463-471. doi: 10.1007/s12288-020-01374-w. Epub 2020 Oct 27.
本文引用的文献
1
Quantifying the financial burden of households' out-of-pocket payments on medicines in India: a repeated cross-sectional analysis of National Sample Survey data, 1994-2014.量化印度家庭药品自付费用的经济负担：1994-2014 年全国抽样调查数据的重复横断面分析。
BMJ Open. 2018 May 31;8(5):e018020. doi: 10.1136/bmjopen-2017-018020.
2
Cost Effectiveness of Hematopoietic Stem Cell Transplantation Compared with Transfusion Chelation for Treatment of Thalassemia Major.重型地中海贫血患者采用造血干细胞移植与输血螯合治疗的成本效果比较。
Biol Blood Marrow Transplant. 2018 Oct;24(10):2119-2126. doi: 10.1016/j.bbmt.2018.04.005. Epub 2018 Apr 16.
3
Country-Level Macroeconomic Indicators Predict Early Post-Allogeneic Hematopoietic Cell Transplantation Survival in Acute Lymphoblastic Leukemia: A CIBMTR Analysis.国家层面的宏观经济指标可预测急性淋巴细胞白血病患者异基因造血细胞移植后早期的生存情况：CIBMTR 分析。
Biol Blood Marrow Transplant. 2018 Sep;24(9):1928-1935. doi: 10.1016/j.bbmt.2018.03.016. Epub 2018 Mar 19.
4
Freezing the graft is not necessary for autotransplants for plasma cell myeloma and lymphomas.对于浆细胞骨髓瘤和淋巴瘤的自体移植，冷冻移植物并非必要。
Bone Marrow Transplant. 2018 Apr;53(4):457-460. doi: 10.1038/s41409-017-0047-7. Epub 2018 Jan 12.
5
Post-Transplant Cyclophosphamide as Sole Graft-versus-Host Disease Prophylaxis Is Feasible in Patients Undergoing Peripheral Blood Stem Cell Transplantation for Severe Aplastic Anemia Using Matched Sibling Donors.异基因外周血造血干细胞移植治疗重型再生障碍性贫血中，采用同胞供者，环磷酰胺作为唯一移植物抗宿主病预防方案是可行的。
Biol Blood Marrow Transplant. 2018 Mar;24(3):494-500. doi: 10.1016/j.bbmt.2017.10.034. Epub 2017 Oct 31.
6
Cost and quality issues in establishing hematopoietic cell transplant program in developing countries.发展中国家建立造血细胞移植项目中的成本与质量问题。
Hematol Oncol Stem Cell Ther. 2017 Dec;10(4):167-172. doi: 10.1016/j.hemonc.2017.05.017. Epub 2017 Jul 14.
7
Cost-Effectiveness of Autologous Stem Cell Treatment as Compared to Conventional Chemotherapy for Treatment of Multiple Myeloma in India.印度自体干细胞治疗与传统化疗治疗多发性骨髓瘤的成本效益比较。
Indian J Hematol Blood Transfus. 2017 Mar;33(1):31-40. doi: 10.1007/s12288-017-0776-1. Epub 2017 Jan 11.
8
Health Care in India.印度的医疗保健
Neurol Clin. 2016 Nov;34(4):1103-1114. doi: 10.1016/j.ncl.2016.06.005.
9
Treatment rates of paediatric acute myeloid leukaemia: a view from three tertiary centres in India - response to Gupta et al.小儿急性髓系白血病的治疗率：来自印度三个三级医疗中心的观点——对古普塔等人的回应
Br J Haematol. 2016 Oct;175(2):347-349. doi: 10.1111/bjh.13857. Epub 2015 Dec 2.
10
Immunosuppressive Therapy and Bone Marrow Transplantation for Aplastic Anaemia--The CMC Experience.再生障碍性贫血的免疫抑制治疗与骨髓移植——中国医学科学院血液学研究所的经验
J Assoc Physicians India. 2015 Mar;63(3 Suppl):36-40.
Zotero 插件